SC 13G | 2024-02-12 | TOCQUEVILLE ASSET MANAGEMENT L.P. | CHAMPIONS ONCOLOGY, INC. | 684,578 | 5.0% | EDGAR |
SC 13G/A | 2022-02-14 | West Elk Partners, LP | CHAMPIONS ONCOLOGY, INC. | 1,093,387 | 8.1% | EDGAR |
SC 13G | 2021-07-23 | West Elk Partners, LP | CHAMPIONS ONCOLOGY, INC. | 676,944 | 5.1% | EDGAR |
SC 13G/A | 2018-08-07 | Fields Ephraim G | CHAMPIONS ONCOLOGY, INC. | 0 | 0.0% | EDGAR |
SC 13D/A | 2017-08-08 | PESSIN NORMAN H | CHAMPIONS ONCOLOGY, INC. | 742,161 | 6.8% | EDGAR |
SC 13D | 2017-01-13 | PESSIN NORMAN H | CHAMPIONS ONCOLOGY, INC. | 572,517 | 1.0% | EDGAR |
SC 13G | 2016-12-13 | Fields Ephraim G | CHAMPIONS ONCOLOGY, INC. | 635,791 | 5.8% | EDGAR |
SC 13D/A | 2016-10-28 | PAR INVESTMENT PARTNERS LP | CHAMPIONS ONCOLOGY, INC. | 444,005 | 4.0% | EDGAR |
SC 13D | 2015-03-24 | New Enterprise Associates 14, L.P. | CHAMPIONS ONCOLOGY, INC. | 29,062,500 | 25.4% | EDGAR |
SC 13D/A | 2015-03-23 | ACKERMAN JOEL | CHAMPIONS ONCOLOGY, INC. | 11,043,102 | 9.9% | EDGAR |
SC 13D/A | 2015-03-23 | Morris Ronnie | CHAMPIONS ONCOLOGY, INC. | 11,025,327 | 9.9% | EDGAR |
SC 13D/A | 2015-03-23 | PAR INVESTMENT PARTNERS LP | CHAMPIONS ONCOLOGY, INC. | 11,891,666 | 11.0% | EDGAR |
SC 13D/A | 2015-03-16 | Battery Ventures IX, L.P. | CHAMPIONS ONCOLOGY, INC. | 29,584,277 | 19.3% | EDGAR |
SC 13D/A | 2013-03-19 | PAR INVESTMENT PARTNERS LP | CHAMPIONS ONCOLOGY, INC. | 11,000,000 | 16.2% | EDGAR |
SC 13D | 2013-02-04 | Morris Ronnie | CHAMPIONS ONCOLOGY, INC. | 4,939,425 | 7.0% | EDGAR |
SC 13D | 2013-02-01 | ACKERMAN JOEL | CHAMPIONS ONCOLOGY, INC. | 4,939,425 | 7.0% | EDGAR |
SC 13D/A | 2013-01-30 | Battery Ventures IX, L.P. | CHAMPIONS ONCOLOGY, INC. | 17,377,285 | 25.4% | EDGAR |
SC 13D | 2013-01-30 | PAR INVESTMENT PARTNERS LP | CHAMPIONS ONCOLOGY, INC. | 11,000,000 | 16.2% | EDGAR |
SC 13D/A | 2011-06-23 | Battery Ventures IX, L.P. | CHAMPIONS ONCOLOGY, INC. | 9,293,739 | 18.8% | EDGAR |
SC 13D | 2011-04-14 | Battery Ventures IX, L.P. | CHAMPIONS ONCOLOGY, INC. | 6,224,429 | 12.6% | EDGAR |